Vanguard Group’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $473M | Buy |
5,413,690
+1,156,461
| +27% | +$94.7M | 0.01% | 1096 |
|
|
2025
Q3 | $283M | Sell |
4,257,229
-101,366
| -2% | -$5.76M | ﹤0.01% | 1358 |
|
|
2025
Q2 | $241M | Buy |
4,358,595
+81,377
| +2% | +$3.91M | ﹤0.01% | 1425 |
|
|
2025
Q1 | $207M | Buy |
4,277,218
+57,181
| +1% | +$2.4M | ﹤0.01% | 1465 |
|
|
2024
Q4 | $163M | Buy |
4,220,037
+3,956
| +0.1% | +$172K | ﹤0.01% | 1634 |
|
|
2024
Q3 | $190M | Buy |
4,216,081
+972,608
| +30% | +$39.3M | ﹤0.01% | 1569 |
|
|
2024
Q2 | $112M | Buy |
3,243,473
+50,502
| +2% | +$1.48M | ﹤0.01% | 1775 |
|
|
2024
Q1 | $92.4M | Buy |
3,192,971
+39,055
| +1% | +$1.06M | ﹤0.01% | 1906 |
|
|
2023
Q4 | $72.3M | Sell |
3,153,916
-74,478
| -2% | -$1.3M | ﹤0.01% | 2024 |
|
|
2023
Q3 | $53.8M | Buy |
3,228,394
+80,639
| +3% | +$1.56M | ﹤0.01% | 2096 |
|
|
2023
Q2 | $86.9M | Sell |
3,147,755
-93,538
| -3% | -$2.34M | ﹤0.01% | 1927 |
|
|
2023
Q1 | $74.5M | Buy |
3,241,293
+143,579
| +5% | +$2.41M | ﹤0.01% | 1971 |
|
|
2022
Q4 | $33.8M | Buy |
3,097,714
+154,947
| +5% | +$1.31M | ﹤0.01% | 2367 |
|
|
2022
Q3 | $24.8M | Buy |
2,942,767
+208,002
| +8% | +$1.97M | ﹤0.01% | 2541 |
|
|
2022
Q2 | $21.6M | Buy |
2,734,765
+404,691
| +17% | +$4.89M | ﹤0.01% | 2603 |
|
|
2022
Q1 | $55.2M | Sell |
2,330,074
-18,092
| -0.8% | -$510K | ﹤0.01% | 2254 |
|
|
2021
Q4 | $80.3M | Sell |
2,348,166
-5,620
| -0.2% | -$178K | ﹤0.01% | 2098 |
|
|
2021
Q3 | $41.7M | Buy |
2,353,786
+65,752
| +3% | +$2.8M | ﹤0.01% | 2459 |
|
|
2021
Q2 | $103M | Buy |
2,288,034
+147,487
| +7% | +$4.87M | ﹤0.01% | 1990 |
|
|
2021
Q1 | $55.4M | Buy |
2,140,547
+122,910
| +6% | +$3.11M | ﹤0.01% | 2257 |
|
|
2020
Q4 | $40.7M | Buy |
2,017,637
+465,178
| +30% | +$10M | ﹤0.01% | 2313 |
|
|
2020
Q3 | $30.4M | Buy |
1,552,459
+132,098
| +9% | +$2.48M | ﹤0.01% | 2270 |
|
|
2020
Q2 | $25.1M | Buy |
1,420,361
+428,892
| +43% | +$5.38M | ﹤0.01% | 2307 |
|
|
2020
Q1 | $7M | Buy |
991,469
+1,684
| +0.2% | +$12.6K | ﹤0.01% | 2795 |
|
|
2019
Q4 | $6.98M | Buy |
989,785
+54,243
| +6% | +$539K | ﹤0.01% | 3030 |
|
|
2019
Q3 | $11.2M | Buy |
935,542
+135,058
| +17% | +$1.7M | ﹤0.01% | 2756 |
|
|
2019
Q2 | $9.69M | Buy |
800,484
+100,960
| +14% | +$1.12M | ﹤0.01% | 2875 |
|
|
2019
Q1 | $8.79M | Buy |
699,524
+39,744
| +6% | +$351K | ﹤0.01% | 2895 |
|
|
2018
Q4 | $4.44M | Buy |
659,780
+129,285
| +24% | +$1.03M | ﹤0.01% | 3129 |
|
|
2018
Q3 | $5.46M | Buy |
530,495
+13,341
| +3% | +$115K | ﹤0.01% | 3201 |
|
|
2018
Q2 | $3.48M | Sell |
517,154
-7,304
| -1% | -$56.1K | ﹤0.01% | 3334 |
|
|
2018
Q1 | $4.51M | Buy |
524,458
+41,913
| +9% | +$789K | ﹤0.01% | 3191 |
|
|
2017
Q4 | $10M | Buy |
482,545
+126,690
| +36% | +$2.25M | ﹤0.01% | 2816 |
|
|
2017
Q3 | $6.29M | Buy |
355,855
+30,460
| +9% | +$422K | ﹤0.01% | 3021 |
|
|
2017
Q2 | $3.68M | Buy |
325,395
+11,881
| +4% | +$127K | ﹤0.01% | 3197 |
|
|
2017
Q1 | $4.02M | Buy |
313,514
+3,435
| +1% | +$55.4K | ﹤0.01% | 3147 |
|
|
2016
Q4 | $6.82M | Buy |
310,079
+167,611
| +118% | +$3.74M | ﹤0.01% | 2918 |
|
|
2016
Q3 | $3.01M | Buy |
+142,468
| New | +$1.95M | ﹤0.01% | 3230 |
|
Other funds holding PTGX
FCM
RI
JJ
